Cellular Pathology Market

Segmentation By Product Type {Consumables (Fixatives, Stains, Reagents and Dyes) and Probes (Antibodies, and Kits)}; By Test Type; By Technique Type; By Application; By Instruments Type; By End User – Global Demand Analysis & Opportunity Outlook 2028

Buy Now
Report ID: 1111 | Published On: Feb 07, 2023
Request Free Sample Copy

Growth Drivers

Upwelling Demand For Pathological Service Resulting From High Number Of Cancer Patients

According to the World Health Organization, cancer is the second leading cause of death globally, and it had accounted for an estimated 9.6 million deaths in 2018. Cancer is the leading cause of death worldwide, with an estimated 9.6 million deaths in 2018.  Around the globe, 1 in 6 deaths is due to cancer. Undiagnosed rate, late-stage presentation, and inaccessible treatment are common. In 2017, only 26% of low-income countries reported that pathology services were generally available in the public sector 


There is considerable potential to increase cellular pathology markets in populated countries this is owing to the fact that there is a substantial increase in the aging population and an increase in the number of patients suffering from chronic diseases. Also, prevalence of chronic diseases, development of technology, and growth of geriatric populations, increased investment in diagnostic research by non-governmental and governmental organizations, as well as market access to accredited players in the region are to boost the cellular pathology market. There also has been an increase in the share of international players in the market which is contributing to the better availability of modern, innovative materials and anatomical pathology tools.

Rising Expenditure On Health Service Sector And Rise In Elderly Population

According to the report published by WHO two years into the era of sustainable development goals, global spending on health continues to rise. That is US $ 7.8 trillion in 2017 or about 10% of GDP and $ 1,080 per capita which is increased from the US $ 7.6 trillion in 2016. The healthcare sector is expanding faster than the economy. Between 2000 and 2017, global health spending rose 3.9% year over year, while the economy grew 3.0% year over year.

The market demand is soaring on the back of rising health care costs, emerging aging populations and the increasing use and effectiveness of biomarkers to diagnose diseases. Continuous technological advances that have led to more sophisticated anatomical pathology methods have also benefited market demand. This is especially true for the industrialized nations of the world, which provides significantly to research and development of pathological methods, especially in the field of diagnosis and treatment of diseases. The developing countries are also seeing an increase in the demand for healthcare facilities owing to the efforts and government initiatives to raise awareness of new emerging technologies.

Get more information on this report: Request Sample PDF

Market Size and Forecast

With the increased number of cases for diseases are seeing a new height the importance of disease detection is also soaring. The cellular pathology market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. The market is segmented by product, by application, by test, by technique, by end-user, by instrument. In the product type, it is further segmented into consumables, probes, antibodies, and kits out of these, antibodies and kits are to experience the highest growth in the product segment, as they are widely used in testing at various labs and diagnostic centers owing to the fact, they are easy to use and quick result delivering. By application type, Disease diagnosis is expected to be at elevated state on account of the graph for disease, infections is soaring day by day so the demand for disease diagnosis is increasing. Genetic testing is also in demand owing to an increase in incidents of genetic diseases. The high demand for histopathological diagnosis is on the back of the increase in the number of cancer patients. Histopathology refers to the study of a biopsy. The sample is processed, and histological sections are mounted on a glass slide. This diagnosis gives accurate results of the presence of disease in the body. This is a very necessary process among doctors and pathologists to avoid errors that occur during the diagnosis phase.


 Merging Of The Markets And Inability Of Underdeveloped Countries To Adopt Such Technological Advances.

Despite the growing market for the cellular pathology, it may face restraints in growth owing to the various players entering the market and thus increasing the market consolidation which acts as a restraint. Also, many underdeveloped countries don't have such funds or public spending on such a technologically advanced market sector which may create a stagnant front for the market growth of the product.

Market Segmentation

Our in-depth analysis of the cellular pathology market includes the following segments:

By Product Type

  • Consumables
  • Reagents
  • Fixatives
  • Stains and dyes
  • Antibodies
  • Kits
  • Probes

By Application

  • Disease diagnosis
  • Cardiology
  • Oncology
  • Hepatology
  • Nephrology
  • Drug discovery

By End User

  • Diagnostic laboratories
  • Hospitals and clinics
  • Ambulatory surgical centers
  • Academic and research organizations

By Test Type

  • Histopathology
  • Cytopathology
  • Surgical pathology

By Technique Type

  • Special staining
  • Immunohistochemistry
  • Electron microscopy
  • Genetic testing

By Region

Based on regional analysis, the cellular pathology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America, followed by Europe, holds a significant share of the cellular pathology market as the region is a The growing pervasiveness of chronic diseases, mounting health care costs, superior infrastructure for hospitals and clinical laboratories, and the presence of key market players in the region are driving the expansion of the cellular pathology market in North America and European region. Asia Pacific region is expected to show significant growth as in the developed countries, health scientists and researchers are trying to provide end-to-end services to consumers to tackle the risk of diseases in humans.

The cellular pathology market is further classified based on region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • The Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

In The News

  • On April 2020, The University of Gothenburg released a statement announcing that it has developed a new blood test for Alzheimer's disease. This cellular pathology method is based on measuring specific variants of tau protein in normal blood samples, making the test relatively easy and inexpensive to perform and it will help the Alzheimer patients with easy and fast detection.

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample